The Hepatitis C Care Cascade: From Diagnosis to Care and Treatment in British Columbia

At the PAN Fall Conference, we learned from Dr. Lianping (Mint) Ti about short-course direct-acting antiviral (DAA) drugs for hepatitis C (HCV). These well-tolerated drugs have demonstrated cure rates of 95% and have been available in British Columbia (BC) since 2014, but their dispensation has been limited to individuals with advanced liver disease due to their high cost.

Findings from a recently published paper on the population level cascade of care for HCV in BC demonstrate the need for greater access to liver care and treatment for individuals living with HCV. According to Dr. Naveed Janjua and his colleagues, data from the BC Hepatitis Testers Cohort (BC-HTC; click here for more information about the cohort) indicates that as of 2012, only 32% percent of the 54,902 people diagnosed with HCV in BC had accessed liver care. Of these diagnosed individuals, only 12% had initiated treatment for hepatitis C and only 7% had achieved a sustained virologic response, defined as an undetectable HCV RNA level measured twelve weeks after completing treatment.

It is also important to note that Janjua and his colleagues estimate that as of December 31, 2012, 18,301 residents of BC were HCV antibody positive but undiagnosed. While it may seem surprising that an estimated 25% of HCV infections in BC are undiagnosed, Janjua et al. cite a 2011 paper by Maxim Trubnikov and colleagues from the Public Health Agency of Canada that suggests 20–44% of HCV infections in Canada are undiagnosed. These statistics illuminate the need for a testing strategy to reach those who are undiagnosed and, as a result, unlinked to care.

Janjua et al.’s findings on the cascade of care for people living with both HIV and HCV also demonstrate the need for accessible interventions. While HIV and HCV co-infected individuals are 6% of the 52,902 people diagnosed with HCV in BC, they are 10%, or 957 people, of the group of people accessing liver care. Of this 10%, however, only 5%, or 408 people, have ever been dispensed treatment. These numbers demonstrate that about 50% of individuals in the co-infected group fall off the cascade of care between these stages, highlighting the gaps that exist between a positive HCV diagnosis and retention in care and treatment.

Fortunately, options for treatment are about to become more accessible for individuals living with HCV in BC, Ontario and Saskatchewan. In February 2017, the BC Ministry of Health announced that thousands of British Columbians living with hepatitis C will have better access to treatment as a result of negotiations brokered by the pan-Canadian Pharmaceutical Alliance (pCPA) to improve the costs of these drugs for the BC, Ontario and Saskatchewan governments. Starting around March 21, 2017, physicians in BC can apply on behalf of their patients for coverage to a set of more effective HCV drugs.

In March 2018, coverage restrictions related to disease progression will be lifted completely and BC PharmaCare will provide coverage for any British Columbian living with chronic hepatitis C regardless of the type or severity of their disease. In their paper, Janjua and his colleagues explained how access to drugs such as these are “expected to be a game changer in preventing progressive liver disease.”

We can only hope that access to these better-tolerated drugs will help close the gap between diagnosis, care, and treatment for individuals living with HCV in British Columbia, Ontario and Saskatchewan. As Janjua and his colleagues remind us, “for these drugs to have major population-level impact on morbidity and mortality, screening efforts must reach undiagnosed individuals, diagnosed individuals must be linked with care and people remain engaged with care to be assessed for and receive treatment.”

Questions? Feedback? Get in touch!
Heather Holroyd, Community Based Research and Evaluation Projects Contractor
[email protected]
Posted in News, Research | Tagged , ,

CAHR 2017 Ancillary Event – CHIWOS: Community K ‘Tea’ E Event

Posted in Event | Tagged , ,

CAHR 2017 Ancillary Event – WATCH: Re-Imagining Strategies to Counter the Criminalization of Women Living with HIV in Canada

Posted in Event | Tagged , ,

CAHR Ancillary Event – Capacity-Building or Capacity Bridging: Reenvisioning CBR

Posted in CBR Musings, Event | Tagged ,

Webinar – Two Spirit! Let’s Hear It! – An Introduction to Two-Spirit Health

Date and Time:
April 12th, 2017
10:00 AM (PST)
Registration Details: GoToWebinar – Link
Please note webinar registration is limited to 500 participants. This webinar will be recorded; by registering for this webinar you are providing your consent to this recording. The webinar registration and delivery is in English only.
Under Canada’s anti-spam legislation, by registering for this webinar, you agree to receive information from the NCCAH regarding knowledge resources, publications and activities. We will send a notice through this mailing list when the digital resources from this webinar are available online. We won’t share your email with anyone and you can unsubscribe at any time.
Two Spirit! Let’s Hear It! – An Introduction to Two-Spirit Health
In this webinar, Dr. Sarah Hunt will provide an introduction to the health of Two-Spirit people. First, the diversity of meanings ascribed to Two-Spirit will be discussed, as a term used to describe an array of Indigenous identities and expressions of gender and sexuality. Within a social determinants framework, an overview of the impacts of colonization will be provided as a key component of understanding the health of Two-Spirit people. A strengths-based approach will be used to present an array of practical measures health practitioners, policy makers, and researchers can use to foster Two-Spirit health. The webinar will complement the recently released NCCAH publication An Introduction to the Health of Two-Spirit People: Historical, contemporary and emergent issues.
Learning Objectives:
  • Develop a strengths-based framework for understanding the health of Two-Spirit people.
  • Develop a critical analysis of how Two-Spirit health is currently framed in health literature.
  • Develop an understanding of key health determinants of Two-Spirit people within an intersectional decolonial framework.
  • Learn practical measures that can be employed in creating culturally safe, welcoming and validating approaches to working with Indigenous people and families which include the recognition of Two-Spirit people.
Speaker Bio:
Dr. Sarah Hunt, Assistant Professor, First Nations and Indigenous Studies and Department of Geography, University of British Columbia
Dr. Sarah Hunt is a Kwagiulth researcher, writer and activist whose scholarship builds on 15 years of collaborating with Indigenous communities to address diverse issues related to health, justice, gender and sexuality. She was awarded a Governor General’s Gold Medal for her doctoral research which investigated the relationship between law and violence in ongoing neocolonial relations in BC, asking how violence gains visibility through Indigenous and Canadian socio-legal discourse and action. Sarah is assistant professor in First Nations and Indigenous Studies and the Department of Geography at UBC. Her recent publications can be accessed at
Recommended Reading:
Hunt, S. (2016). An Introduction to the Health of Two-Spirit People: Historical, contemporary and emergent issues. Prince George, BC: National Collaborating Centre for Aboriginal Health.

Click to Register for the NCCAH Webinar
April 12th, 2017, 10 am (PST)

Posted in Webinar | Tagged ,

Visioning Health II Womens’ Research Retreat

Posted in PHA Retreat, PLDI News | Tagged ,